Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D ; volume:18 ; number:1 ; day:25 ; month:2 ; year:2019 ; pages:1-12 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (25.2.2019), 1-12, 12.2019
- Urheber
-
La Sala, Lucia
Mrakic-Sposta, Simona
Tagliabue, Elena
Prattichizzo, Francesco
Micheloni, Stefano
Sangalli, Elena
Specchia, Claudia
Uccellatore, Anna Chiara
Lupini, Silvia
Spinetti, Gaia
de Candia, Paola
Ceriello, Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-019-0824-2
- URN
-
urn:nbn:de:101:1-2019032320105244994179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:52 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- La Sala, Lucia
- Mrakic-Sposta, Simona
- Tagliabue, Elena
- Prattichizzo, Francesco
- Micheloni, Stefano
- Sangalli, Elena
- Specchia, Claudia
- Uccellatore, Anna Chiara
- Lupini, Silvia
- Spinetti, Gaia
- de Candia, Paola
- Ceriello, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder
Age-associated network controllability changes in first episode drug-naïve schizophrenia
Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder
The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia
Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome
Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder
Age-associated network controllability changes in first episode drug-naïve schizophrenia
Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder
The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia
Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome
Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder
Age-associated network controllability changes in first episode drug-naïve schizophrenia
Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder
The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia
Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome
Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease